Preactivation of B lymphocytes does not enhance mouse mammary tumor virus infection.


Autoria(s): Finke D.; Mortezavi L.; Acha-Orbea H.
Data(s)

1998

Resumo

We investigated whether mouse mammary tumor virus (MMTV) favors preactivated or naive B cells as targets for efficient infection. We have demonstrated previously that MMTV activates B cells upon infection. Here, we show that polyclonal activation of B cells leads instead to lower infection levels and attenuated superantigen-specific T-cell responses in vivo. This indicates that naive small resting B cells are the major targets of MMTV infection and that the activation induced by MMTV is sufficient to allow efficient infection.

Identificador

https://serval.unil.ch/?id=serval:BIB_07B174E96073

isbn:0022-538X (Print)

pmid:9696877

isiid:000075328600090

Idioma(s)

en

Fonte

Journal of Virology, vol. 72, no. 9, pp. 7688-7691

Palavras-Chave #Animals; B-Lymphocytes/drug effects; B-Lymphocytes/immunology; DNA, Viral; Lymphocyte Activation; Mammary Tumor Virus, Mouse/genetics; Mammary Tumor Virus, Mouse/physiology; Mice; Mice, Inbred BALB C
Tipo

info:eu-repo/semantics/article

article